Trevi TherapeuticsTRVI
那斯達克 · USD
16.79
-1.17
(-6.51%)
收盤 08/29 03:59 (UTC+8)
08/29 03:59 (UTC+8)
Trevi TherapeuticsTRVI
16.79
-1.17
(-6.51%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 20,509 | 14,912 | 10,220 | 13,916 | 13,722 | 11,470 | 12,243 | 14,086 | 13,289 | - |
研發費用 | 15,152 | 9,941 | 6,193 | 10,085 | 9,389 | 7,811 | 9,328 | 11,224 | 10,021 | 8,804 |
推銷及管理費用 | 5,357 | 4,971 | 4,027 | 3,831 | 4,333 | 3,659 | 2,915 | 2,862 | 3,268 | 3,102 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -20,509 | -14,912 | -10,220 | -13,916 | -13,722 | -11,470 | -12,243 | -14,086 | -13,289 | -11,906 |
其他收入及費用 | 2,693 | 1,700 | 1,888 | 2,098 | 1,400 | 1,119 | 845 | 815 | 930 | 997 |
利息費用 | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
稅前純益 | -17,816 | -13,212 | -8,332 | -11,818 | -12,322 | -10,351 | -11,399 | -13,272 | -12,360 | -10,910 |
所得稅 | -19 | -20 | -16 | -16 | -21 | -11 | 16 | -30 | -8 | -8 |
稅後純益 | -17,797 | -13,192 | -8,316 | -11,802 | -12,301 | -10,340 | -11,415 | -13,242 | -12,352 | -10,902 |
基本每股稅後盈餘(元) | -0.11 | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 |
稀釋每股稅後盈餘(元) | -0.12 | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 |
基本平均股數(千股) | 156602.00 | 145592.00 | 145502.00 | 145104.00 | 130350.00 | 117610.00 | 106009.00 | 101282.00 | 101041.00 | 99517.00 |
稀釋平均股數(千股) | 156602.00 | 145592.00 | 145502.00 | 145104.00 | 130350.00 | 117610.00 | 106009.00 | 101282.00 | 101041.00 | 99517.00 |
還原基本每股稅後盈餘(元) | -0.11 | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 |
還原稀釋每股稅後盈餘(元) | -0.12 | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 |
還原基本平均股數(千股) | 156,602 | 145,592 | 145,502 | 145,104 | 130,350 | 117,610 | 106,009 | 101,282 | 101,041 | 99,517 |
還原稀釋平均股數(千股) | 156,602 | 145,592 | 145,502 | 145,104 | 130,350 | 117,610 | 106,009 | 101,282 | 101,041 | 99,517 |
EBITDA(千元) | -18,299 | -13,609 | -8,863 | -12,078 | -12,667 | -10,709 | -11,657 | -13,588 | -12,657 | -11,255 |